Skip to main content
. 2024 Apr 22;6(1):vdae037. doi: 10.1093/noajnl/vdae037

Figure 1.

Figure 1.

Efficacy outcomes of tirabrutinib treatment. The Kaplan–Meier curves of (A, B) duration of response (DOR), (C, D) progression-free survival (PFS), and (E, F) overall survival (OS) in all patients and each dose group are shown.